SOURCE: ONE Bio, Corp.

March 02, 2010 08:50 ET

ONE Bio Signs Distribution Agreement With China's Largest Meat Producer

MIAMI, FL--(Marketwire - March 2, 2010) - ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its subsidiary, United Green Technology, Inc. ("UGTI") through its Chinese operating unit, signed a distribution agreement with Shineway Group (formerly "Henan Shuanghui Investment & Development Co. Ltd.") China's largest meat processing manufacturer for distribution of the Company's organic bamboo shoots.

Shineway Group anticipates increasing purchasing volumes starting 2010 and committed to the annual purchase of a minimum of 10,000 Tons (valued at 8 million usd) of Bamboo Shoots by 2011. As of Feb, purchase order placed by Shineway reached 100 tons and sales delivered from the pilot reached over 11 Tons.

"We are pleased to gain the business of Shineway, the largest meat processing company in China. Committed minimum purchase volumes starting in 2011 are expected to translate into sales of 8 million usd per annum. We appreciate the confidence Shineway Group has shown in our business," stated Jinrong Tang, Sr. Vice President (China). "We are currently aggressively expanding distribution in China and Japan and plan to break into the US market later this year," added Tang.

"I want to congratulate our Chinese management team for signing the distribution agreement with Shineway. Bamboo shoots are an important part of our organic products line up and a significant contributor to our profits. We are seeing a continued increase in the consumption of organic products and we intend to take advantage of it," stated ONE's CEO Marius Silvasan. "Our growth strategy is based on continued organic growth coupled with strategic acquisitions of high margin/high profit companies in the organic products and natural and health supplements segments," added Silvasan.

About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTCBB: ONBI) ( headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE's growth plan targets an aggressive acquisition driven strategy supported by strong organic growth. Through ONE, small private companies gain access to capital, experienced management and strategic insight. ONE builds strong synergies amongst all subsidiaries to enhance shareholder value. ONE is working with each subsidiary to promote organic and acquisition driven growth.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information

  • Company and Investor Relation Contact:
    Jeanne Chan
    Senior VP
    Tel. +877.544.2288

    Investor Relations & Corporate Communications